Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

AstraZeneca's COVID-19 Therapy Approved In Britain As Preventive Option

Britain's Medicines and Healthcare products Regulatory Agency (MHRA) has approved AstraZeneca Plc's (NASDAQ:AZN) antibody-based COVID-19 treatment to prevent infections in adults with poor immune response.

The approval covers Evusheld for adults who are not currently infected (or know exposure to) and for whom vaccination is not recommended.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.